Lung Injury  >>  Cytovene (ganciclovir)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cytovene (ganciclovir) / Roche
GRAIL, NCT01335932: Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure

Completed
2
160
US
IV Ganciclovir, Placebo
Fred Hutchinson Cancer Center, National Heart, Lung, and Blood Institute (NHLBI), Genentech, Inc.
Acute Lung Injury, Acute Respiratory Distress Syndrome, Respiratory Failure
06/16
10/16

Download Options